Sickle Cell Disease Treatment Market Size, Share, Growth Analysis, By Treatment type(Pharmaceuticals and supportive care), By End user(Hospitals, clinics, research institutes, and others), By Region - Industry Forecast 2024-2031

Global Sickle Cell Disease Treatment Market size was valued at USD 2.10 billion in 2022 and is poised to grow from USD 2.55 billion in 2023 to USD 12.03 billion by 2031, growing at a CAGR of 21.4% during the forecast period (2024-2031).

Growing incidence of sickle cell diseases around the world is projected to primarily augment the demand for sickle cell disease treatment. The prevalence of sickle cell disease is especially high in Africa, the Middle East, and India owing to limited early detection, lack of awareness, and genetic predisposition. Increasing investments in the research and development of novel treatments for rare and chronic diseases are also expected to create new opportunities for sickle cell disease treatment companies in the future. Launch of new supportive initiatives by governments and non-profit organizations to promote awareness regarding sickle cell disease treatment will also create new business scope for market players going forward. Increasing availability of novel drugs and expansion of sickle cell disease treatment drug pipelines are also slated to contribute to sickle cell disease treatment market growth in the long run. However, safety issues with novel treatments, complex regulatory landscape for genetic treatments, and lack of awareness are some major constraints that are estimated to slow down the global sickle cell disease treatment industry through 2031 and beyond. 

US Sickle Cell Disease Treatment Market is poised to grow at a sustainable CAGR for the next forecast year.